enoxacin has been researched along with Allergic Reaction in 1 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nunes, IKDC | 1 |
| de Souza, ET | 1 |
| Martins, IRR | 1 |
| Barbosa, G | 1 |
| Moraes Junior, MO | 1 |
| Medeiros, MM | 1 |
| Silva, SWD | 1 |
| Balliano, TL | 1 |
| da Silva, BA | 1 |
| Silva, PMR | 1 |
| Carvalho, VF | 1 |
| Martins, MA | 1 |
| Lima, LM | 1 |
1 other study available for enoxacin and Allergic Reaction
| Article | Year |
|---|---|
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; H | 2020 |